Search | Page 36 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. 2015 Bone Marrow Failure Disease Symposia

    ... myelodysplastic syndromes , aplastic anemia , paroxysmal nocturnal hemoglobinuria , and myeloproliferative neoplasms. The overall ...

    Page last updated 08/28/2015 - 2:23pm.

  2. Blood Basics

    ... Aplastic anemia, myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria are bone marrow failure diseases. ...

    Page last updated 01/23/2014 - 4:09pm.

  3. Pediatric MDS

    What is pediatric MDS, and why is it seldom mentioned in larger discussion about MDS? Pediatric MDS, like adult MDS, is a clonal myeloid malignancy that is typically fi rst spotted as cytopenias (low blood coun...

    Interview last updated 10/24/2012 - 1:31pm.

  4. Making the Most of Office Visits with Your Specialist

    ... syndromes (MDS), aplastic anemia , and paroxysmal nocturnal hemoglobinuria (PNH). Sometimes, it truly can be hard to tell ...

    Interview last updated 10/14/2015 - 9:05am.

  5. 2016 Scientific Symposium

    ... , myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH) are now believed to be linked by similar ...

    Page last updated 09/14/2015 - 1:40pm.

  6. Chief Development Officer

    ... anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure ...

    Page last updated 08/11/2015 - 11:26am.

  7. Ramon V. Tiu, MD

    LFA-3/CD2 Pathway: Potential Target for Immunosuppressive Therapy in Aplastic Anemia Original Research Center:  ...

    Grant Recipient last updated 10/30/2012 - 6:28pm.

  8. Recurrent and Secondary MDS

    Is MDS that returns after treatment(s) have successfully controlled it considered recurrent MDS? The idea of the recurrent MDS is exactly that. If a patient’s MDS has been treated into remission or even control...

    Interview last updated 10/24/2012 - 1:12pm.

  9. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    Were there any presentations at ASH 2012 on the clinical aspects of MDS that you think patients might find particularly interesting? There is some evolution in the classification systems used for MDS. For y...

    Interview last updated 02/07/2013 - 1:28pm.

  10. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    We hear that there is increasing interest and research in the role that genes and genetic mutations have in affecting the course of MDS. Were there any studies of particular significance in this area? Yes, ...

    Interview last updated 02/01/2013 - 4:22pm.